Cipla gets nod for generic version of Shire’s Firazyr

Pharma major Cipla has announced that the company has received the final approval for its Abbreviated New Drug Application (ANDA) for Icatibant Injectable 30mg/3mL from the United States Food and Drug Administration (US FDA).

Cipla’s Icatibant Injectable Pre-Filled Syringe 30mg/3mL is AP-rated generic version of Shire’s Firazyr.The purpose of the Icatibant injection is for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.

  • Related Posts

    CDSCO declares 159 drug samples as NSQs in June

    New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has announced a total of 159 drug samples tested across the country during the month of June, 2026, as Not of…

    Donald Trump reveals 200% tariff plan for generic medicines. Will India exports be hit?

    The decision could hit India hard, as it is the largest exporter of generic drugs to the US. US President Donald Trump has announced steep tariffs on imported generic medicines,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    CDSCO declares 159 drug samples as NSQs in June

    CDSCO declares 159 drug samples as NSQs in June

    Donald Trump reveals 200% tariff plan for generic medicines. Will India exports be hit?

    Donald Trump reveals 200% tariff plan for generic medicines. Will India exports be hit?

    IIT Kanpur scientists’ research reveals how a promising vaccine booster switches on immune cells

    IIT Kanpur scientists’ research reveals how a promising vaccine booster switches on immune cells

    Government takes steps to strengthen primary healthcare services

    Government takes steps to strengthen primary healthcare services

    Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

    Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

    National Health Emergency: Telangana C-section Cluster Spark Critical Alarms as Substandard Drug Suspicions spread Nationwide

    National Health Emergency: Telangana C-section Cluster Spark Critical Alarms as Substandard Drug Suspicions spread Nationwide